Fidelity® MSCI Health Care Index ETF(FHLC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
3-STAR RATING
STRONG BUY
BUY for 119 days
PROFIT SINCE LAST BUY
+24.43% ▲
LAST CLOSE
$90
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for FHLC

11/13/2026: FHLC (3-star) is a STRONG-BUY. BUY for 119 days. Simulated Profits (24.43%). Updated daily EoD!

Fidelity® MSCI Health Care Index ETF (FHLC) provides broad, low-cost exposure to the U.S. healthcare sector, capturing companies across the entire market-capitalization spectrum. Its primary strength lies in its low expense ratio and comprehensive benchmark tracking, making it an efficient tool for investors looking to gain sector-specific exposure. The fund is ideal for long-term investors who want to benefit from demographic and medical innovation trends while mitigating the risks of picking individual company winners. Investors should monitor healthcare policy shifts and regulatory changes, as these are primary risks that can impact the sector's performance. Overall, FHLC serves as a stable, low-cost building block for a well-diversified equity portfolio.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe fund provides exposure to innovative biotechnology and pharmaceutical firms that can drive long-term capital appreciation.
Momentum investorStrong fit while signal remains positiveThe healthcare sector often exhibits strong relative strength trends that momentum investors can capitalize on during market upcycles.
Value investorMixed fitWhile the sector contains many mature, stable firms, the valuation of healthcare stocks can fluctuate significantly based on regulatory risks.
Dividend/Income investorMixed fitMany large-cap pharmaceutical holdings pay reliable dividends, though the fund's primary objective is capital growth rather than income generation.
Low-risk investorMixed fitHealthcare is often considered a defensive sector, but it remains subject to political and regulatory risks that can trigger volatility.

Investor Profile

Ideal Investor Profile

The ideal investor is a long-term growth-oriented individual seeking to gain exposure to the healthcare sector without picking individual stocks.

Suitability

FHLC is best suited for long-term investors or passive index followers who want low-cost, broad healthcare exposure within a diversified portfolio.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMediumSector-specific investments can experience higher volatility than broad market indices due to industry-specific events.
Market riskMediumThe fund is subject to general equity market downturns which impact all securities in the portfolio.
ConcentrationMedium / highBeing invested in a single sector increases exposure to industry-specific shocks compared to a diversified total market fund.
Tracking/expenseLowThe fund's passive management and low expense ratio minimize the impact of tracking error and management fees on returns.
LiquidityLowThe underlying assets are generally highly liquid, reducing the risk of wide spreads during normal market conditions.
Business/sector qualityMediumThe sector's reliance on government reimbursement and FDA regulation introduces structural business risks.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

FHLC experiences moderate volatility typical of the healthcare sector, which is influenced by clinical trial outcomes and regulatory news.

Market Risk

The fund is fully invested in equity securities, meaning it carries the systematic risk of the U.S. stock market and sector-specific risks associated with healthcare policy.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorU.S. Healthcare Stocks99.5This provides broad, diversified exposure to the entire U.S. healthcare ecosystem, ranging from pharmaceutical giants to medical device innovators.
Cash/collateralCash and Cash Equivalents0.5This represents residual cash held for operational purposes and efficient fund management.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type ETF
Historic Profit 51.4%
Avg. Invested days 83
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.